Review on medicinal plants use on peptic ulcers

Background: Peptic ulcer disease (PUD) is a prevalent gastrointestinal disorder worldwide, characterized by damage to the protective mucosal lining of the stomach and duodenum. Its development is primarily associated with Helicobacter pylori infection, prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs), and increased oxidative stress. Although conventional treatments, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists, are widely used and generally effective, their prolonged administration may be associated with adverse effects, antimicrobial resistance, and disease recurrence. These limitations have encouraged researchers to explore safer and more biologically derived therapeutic alternatives. Objective: This review aims to examine recent scientific evidence regarding the therapeutic potential of medicinal plants in the prevention and treatment of peptic ulcer disease, with particular emphasis on their phytochemical constituents and underlying pharmacological mechanisms. Methods: Relevant scientific publications from the past two decades were reviewed using electronic databases, including PubMed, ScienceDirect, Google Scholar, and Scopus. The review considers experimental findings from in vitro and in vivo studies, along with available clinical evidence concerning the gastroprotective and anti-ulcer properties of medicinal plants. Results: Several medicinal plants, including Glycyrrhiza glabra, Curcuma longa, Zingiber officinale, and Aloe vera, have demonstrated promising gastroprotective and ulcer-healing effects. Their biological activities are largely attributed to the presence of phytochemicals such as flavonoids, tannins, polyphenols, and terpenoids. These compounds may protect the gastric mucosa through several mechanisms, including the regulation of gastric acid secretion, enhancement of mucus and bicarbonate production, reduction of reactive oxygen species (ROS), inhibition of inflammatory mediators such as tumour necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), and antimicrobial effects against H. pylori. Some herbal preparations have also demonstrated favourable tolerability in experimental studies, although their comparative safety requires further clinical investigation. Conclusion: Medicinal plants offer considerable potential as sources of bioactive compounds for developing new gastroprotective and anti-ulcer therapies. Nevertheless, their clinical application remains restricted by insufficient large-scale clinical investigations, variations in extraction and formulation procedures, and limited long-term toxicity data. Further research should focus on standardized herbal formulations, pharmacokinetic and bioavailability studies, well-controlled clinical trials, and possible interactions between herbal products and conventional medicines.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24271849
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Review on medicinal plants use on peptic ulcers

Manish Ahire, Namrata Suryawanshi, Sagar Vaidya, Danish Shaikh et al.
2 links
Zenodo (CERN European Organization for Nuclear Research)
Medicinal Plant Research
article

Review on medicinal plants use on peptic ulcers

Manish Ahire, Namrata Suryawanshi, Sagar Vaidya, Danish Shaikh, Pavan Vaidya, Vishal Shejwal, Kanchan Wakchoure, Gayatri Shinde
article en

Abstract

Background: Peptic ulcer disease (PUD) is a prevalent gastrointestinal disorder worldwide, characterized by damage to the protective mucosal lining of the stomach and duodenum. Its development is primarily associated with Helicobacter pylori infection, prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs), and increased oxidative stress. Although conventional treatments, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists, are widely used and generally effective, their prolonged administration may be associated with adverse effects, antimicrobial resistance, and disease recurrence. These limitations have encouraged researchers to explore safer and more biologically derived therapeutic alternatives. Objective: This review aims to examine recent scientific evidence regarding the therapeutic potential of medicinal plants in the prevention and treatment of peptic ulcer disease, with particular emphasis on their phytochemical constituents and underlying pharmacological mechanisms. Methods: Relevant scientific publications from the past two decades were reviewed using electronic databases, including PubMed, ScienceDirect, Google Scholar, and Scopus. The review considers experimental findings from in vitro and in vivo studies, along with available clinical evidence concerning the gastroprotective and anti-ulcer properties of medicinal plants. Results: Several medicinal plants, including Glycyrrhiza glabra, Curcuma longa, Zingiber officinale, and Aloe vera, have demonstrated promising gastroprotective and ulcer-healing effects. Their biological activities are largely attributed to the presence of phytochemicals such as flavonoids, tannins, polyphenols, and terpenoids. These compounds may protect the gastric mucosa through several mechanisms, including the regulation of gastric acid secretion, enhancement of mucus and bicarbonate production, reduction of reactive oxygen species (ROS), inhibition of inflammatory mediators such as tumour necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), and antimicrobial effects against H. pylori. Some herbal preparations have also demonstrated favourable tolerability in experimental studies, although their comparative safety requires further clinical investigation. Conclusion: Medicinal plants offer considerable potential as sources of bioactive compounds for developing new gastroprotective and anti-ulcer therapies. Nevertheless, their clinical application remains restricted by insufficient large-scale clinical investigations, variations in extraction and formulation procedures, and limited long-term toxicity data. Further research should focus on standardized herbal formulations, pharmacokinetic and bioavailability studies, well-controlled clinical trials, and possible interactions between herbal products and conventional medicines.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon